Patent details

Basic Information

Publication number:

EP3090731

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161611769

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATIONS COMPRISING NANOPARTICULATE MELOXICAM

French Title of Invention:

FORMULES À MÉLOXICANE NANOPARTICULAIRE

German Title of Invention:

FORMULIERUNGEN MIT NANOPARTIKULÄREM MELOXICAN

SPC Number:

Dates

Filing date:

27/02/2004

Grant date:

19/09/2018

EP Publication Date:

09/11/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/09/2018

EP B1 Publication Date:

19/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/02/2019

Expiration date:

27/02/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/09/2018

 

 

Name:

Recro Pharma, Inc.

Address:

490 Lapp Road, Malvern, PA 19355, United States (US)

Inventor

1

Name:

Cooper, Eugene R.

Address:

United States (US)

2

Name:

Pruitt, John D.

Address:

United States (US)

3

Name:

Kline, Laura

Address:

United States (US)

4

Name:

Ryde, Tuula

Address:

United States (US)

Priority

Priority Number:

450705 P

Priority Date:

03/03/2003

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/14; A61K 31/5415;

Publication

European Patent Bulletin

Issue number:

201838

Publication date:

19/09/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages